Seagen Inc
Officers & Directors
1. Clay Siegall, Co-Founder, President, Chief Executive Officer, and Chairman of the Board
Dr. Siegall, a pioneer in targeted cancer therapies, co-founded Seagen Inc. in 1998 and under his leadership, Seagen has become a leader in developing innovative cancer treatments that target specific proteins involved in cancer growth and progression.
2. Darren Cline, Executive Vice President, Commercialization
Mr. Cline joined Seagen in 2019 and oversees the commercialization of Seagen's products, including Adcetris and Tukysa, in the United States and around the world.
3. Robin Taylor, Executive Vice President, General Counsel and Corporate Secretary
Ms. Taylor joined Seagen in 2011 and is responsible for overseeing the company's legal affairs and governance matters.
4. Roger Dansey, Chief Medical Officer
Dr. Dansey joined Seagen in 2008 and is responsible for overseeing the company's clinical development program, including the development of new and existing product candidates.
Board of Directors:
1. Clay Siegall, Co-Founder, President, Chief Executive Officer, and Chairman of the Board (see above)
2. Felix Baker, Ph.D., Founding Partner, Baker Bros. Advisors
Dr. Baker is a co-founder of Baker Bros. Advisors LLC and has been investing in biotechnology companies for more than 20 years.
3. Leslie Alexander, Ph.D., President, Lead Enterprise Partners
Dr. Alexander is the President and CEO of Lead Enterprise Partners and has been a member of Seagen's board of directors since 2001.
4. Bruce Montgomery, M.D. Ph.D.
Dr. Montgomery is a former executive at Eli Lilly and Company and is a board-certified hematologist and oncologist.
5. Jill O'Donnell-Tormey, Ph.D., Chief Executive Officer and Director, Cancer Research Institute
Dr. O'Donnell-Tormey is the Chief Executive Officer and Director of the Cancer Research Institute and has been a member of Seagen's board of directors since 2014.
6. Charles Sanders, M.D., Chairman, Cadence Pharmaceuticals, Inc.
Dr. Sanders has extensive experience in the biotech and pharmaceutical industries and currently serves as chairman of Cadence Pharmaceuticals, Inc.
It is worth noting that this information might change, and I advise you to consult with reliable sources for updates in such cases.
Seagen Inc currently has 1200 employees.
|
